Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$209.01 - $232.56 $4.63 Million - $5.15 Million
-22,157 Reduced 12.69%
152,439 $33.3 Million
Q4 2023

Feb 08, 2024

SELL
$197.69 - $227.29 $1.39 Million - $1.6 Million
-7,049 Reduced 3.88%
174,596 $39.7 Million
Q3 2023

Nov 09, 2023

SELL
$201.05 - $221.7 $1.02 Million - $1.13 Million
-5,078 Reduced 2.72%
181,645 $36.5 Million
Q2 2023

Aug 08, 2023

SELL
$211.93 - $241.33 $1.01 Million - $1.15 Million
-4,754 Reduced 2.48%
186,723 $45.1 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $2.19 Million - $2.64 Million
10,244 Added 5.65%
191,477 $43.9 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $262,595 - $320,922
1,289 Added 0.72%
181,233 $42.7 Million
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $202,557 - $259,305
-989 Reduced 0.55%
179,944 $36.9 Million
Q2 2022

Aug 11, 2022

BUY
$213.86 - $277.87 $3.85 Million - $5.01 Million
18,020 Added 11.06%
180,933 $42.4 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $1.03 Million - $1.19 Million
3,979 Added 2.5%
162,913 $43 Million
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $60,566 - $70,068
223 Added 0.14%
158,934 $49.9 Million
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $2.87 Million - $3.22 Million
-10,445 Reduced 6.17%
158,711 $44.7 Million
Q2 2021

Aug 05, 2021

SELL
$251.87 - $278.14 $2.68 Million - $2.96 Million
-10,660 Reduced 5.93%
169,156 $46.7 Million
Q1 2021

May 06, 2021

SELL
$204.88 - $255.03 $2.94 Million - $3.66 Million
-14,354 Reduced 7.39%
179,816 $45.9 Million
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $48,783 - $55,963
261 Added 0.13%
194,170 $39.5 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $1.04 Million - $1.25 Million
-6,226 Reduced 3.11%
193,909 $36.5 Million
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $3.16 Million - $5.08 Million
-27,844 Reduced 12.21%
200,135 $33.2 Million
Q1 2020

May 06, 2020

BUY
$104.32 - $195.28 $1.16 Million - $2.17 Million
11,128 Added 5.13%
227,979 $28.8 Million
Q4 2019

Feb 05, 2020

BUY
$163.48 - $173.61 $1.53 Million - $1.62 Million
9,349 Added 4.51%
216,851 $36.7 Million
Q3 2019

Oct 23, 2019

BUY
$159.77 - $178.1 $1.28 Million - $1.43 Million
8,008 Added 4.01%
207,502 $34.9 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $1.15 Million - $1.38 Million
-8,009 Reduced 3.86%
199,494 $34.5 Million
Q1 2019

May 01, 2019

SELL
$123.7 - $156.3 $1.88 Million - $2.37 Million
-15,186 Reduced 6.82%
207,503 $31.7 Million
Q4 2018

Jan 31, 2019

BUY
$120.82 - $174.09 $227,745 - $328,159
1,885 Added 0.85%
222,689 $28.1 Million
Q3 2018

Nov 07, 2018

SELL
$167.67 - $188.27 $955,718 - $1.07 Million
-5,700 Reduced 2.52%
220,804 $38.3 Million
Q2 2018

Aug 06, 2018

BUY
$160.33 - $189.41 $870,271 - $1.03 Million
5,428 Added 2.46%
226,504 $40.7 Million
Q1 2018

May 02, 2018

SELL
$161.53 - $178.11 $250,371 - $276,070
-1,550 Reduced 0.7%
221,076 $35.8 Million
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $748,089 - $828,767
5,055 Added 2.32%
222,626 $35.5 Million
Q3 2017

Nov 06, 2017

BUY
$149.47 - $160.56 $32.5 Million - $34.9 Million
217,571
217,571 $32.8 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.